Immunotherapy of neuroblastoma by an Interleukin-21-secreting cell vaccine involves survivin as antigen

By Croce Michela  

Cancer Immunology, Immunotherapy, Vol. 57, Iss. 11, 2008-11 ,pp. : 1625-1634

Springer Publishing Company

Access to resources Recommend Favorite

Neuroblastoma

By Castleberry R.P.  

European Journal of Cancer, Vol. 33, Iss. 9, 1997-08 ,pp. : 1430-1437

Elsevier

Access to resources Recommend Favorite

Treatment of neuroblastoma stage 4 with 131 I-meta-iodo-benzylguanidine, high-dose chemotherapy and immunotherapy. A pilot study

By Klingebiel T.   Bader P.   Bares R.   Beck J.   Hero B.   Jurgens H.   Lang P.   Niethammer D.   Rath B.   Handgretinger R.  

European Journal of Cancer, Vol. 34, Iss. 9, 1998-08 ,pp. : 1398-1402

Elsevier

Access to resources Recommend Favorite

Induction of protective immune responses against NXS2 neuroblastoma challenge in mice by immunotherapy with GD2 mimotope vaccine and IL-15 and IL-21 gene delivery

By Kowalczyk Aleksandra   Wierzbicki Andrzej   Gil Margaret   Bambach Barbara   Kaneko Yutaro   Rokita Hanna   Repasky Elizabeth   Fenstermaker Robert   Brecher Martin   Ciesielski Michael   Kozbor Danuta  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 9, 2007-09 ,pp. : 1443-1458

Springer Publishing Company

Access to resources Recommend Favorite

Angiogenesis and anti-angiogenesis in neuroblastoma

By Ribatti D.   Vacca A.   Nico B.   De Falco G.   Giuseppe Montaldo P.   Ponzoni M.  

European Journal of Cancer, Vol. 38, Iss. 6, 2002-01 ,pp. : 750-757

Elsevier

Access to resources Recommend Favorite